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Abstract: 
 
X-chromosome inactivation (XCI) is a random, permanent, and developmentally early 
epigenetic event that occurs during mammalian embryogenesis. We harness these features of 
XCI to investigate characteristics of early lineage specification events during human 
development. We initially assess the consistency of X-inactivation and establish a robust set of 
XCI-escape genes. By analyzing variance in XCI ratios across tissues and individuals, we find 
that XCI is completed prior to tissue specification and at a time when 6-16 cells are fated for all 
tissue lineages. Additionally, we exploit tissue specific variability to characterize the number of 
cells present at the time of each tissue’s lineage commitment, ranging from approximately 20 
cells in liver and whole blood tissues to 80 cells in brain tissues. By investigating variance of 
XCI ratios using adult tissue, we resolve key features of human development otherwise difficult 




Every cell within female mammalian embryos undergoes the process of X-chromosome 
inactivation (XCI), which silences expression from a single randomly chosen X-allele via 
epigenetic mechanisms1,2,3. The random choice of which allele to inactivate occurs early in 
development and is permanent thereafter with the inactivated allele propagated through each 
cell’s developmental lineage4. As a result, adult females exhibit mosaic X-linked allelic 
expression throughout every tissue within the body, an enduring phenotypic consequence of 
an early embryonic milestone. The random, permanent, and developmentally early nature of 
XCI positions the whole-body mosaicism of X-linked allelic expression as a lineage marker 
reaching back to the earliest embryonic stages5,6. Careful analysis of X-linked allelic 
expression across individuals and tissues can thus reveal whole-body lineage relationships 
stemming from some of the first lineage decisions made during embryogenesis6,7,8,9.   
 
While the probability of inactivation is equal between the X-alleles in humans, variation 
in XCI allelic ratios across individuals is a salient feature of XCI. Deviation from the expected 
XCI allelic ratio of 0.5 can arise through various mechanisms10,11,12 with the most basic being 
the inherent stochasticity of the initial choice of allelic inactivation13. The variability of the initial 
XCI ratio within the embryo is directly linked to the number of cells present during inactivation 
where smaller cell numbers result in increased variability of XCI ratios6. In fact, one can 
estimate the number of cells present at the time of inactivation by analyzing the variance of 
XCI ratios across a population. Several studies using this approach13,14, as well as studies 
using in vitro embryonic models15,16,17, have estimated that XCI occurs in a small stem cell pool 
within the human embryo with estimates as little as 8 cells. The combination of the random 
nature and small pool of cells present during XCI imparts an ever-present basal-level of 
variability in XCI ratios within adult human populations. 
 
The stability of XCI down lineages means that minor cell sampling variation can be used 
as a marker for any process involving selection of a set of cells, i.e., lineage specification6,7. 
While growing evidence indicates XCI is initiated early15,16,17, the timing of XCI completion is 
unclear18 and has important implications for the variance in XCI ratios across early lineages. 
Germ layer specification is the first lineage decision made for all future embryonic tissues and 
occurs during post-implantation embryonic development19, a similar timeframe to XCI. If XCI is 
completed before germ layer specification each germ layer would be specified from the same 
pool of cells with a set XCI ratio (Fig. 1a). The germ layer specific XCI ratio would be 
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dependent on the initial XCI ratio resulting in shared XCI ratios across germ layers (Fig. 1a). In 
contrast, if XCI is completed after germ layer specification, the germ layer specific XCI ratio is 
set independently and is not expected to be shared across the different germ layers (Fig. 1b). 
Consequently, comparing XCI ratios for tissues within either the same or different germ layer 
lineages can reveal the temporal ordering of XCI and germ layer specification. Extending to 
tissue-specific lineages, variability in the number of cells fated for individual tissues will 
generate stereotypic deviations in XCI ratios due to sampling, potentially allowing estimates of 
cell numbers for tissue-specific lineage commitment.    
 
   In this study, we develop an approach to determine the tissue XCI ratio from 
unphased bulk RNA-sequencing data allowing us to assess XCI ratios from any publicly 
available RNA-sequencing dataset. Utilizing the tissue sampling scheme of the Genotype-
Tissue Expression (GTEx v8) project20, we analyze XCI ratios for 49 tissues both within and 
across individuals for 311 female donors (Supp. Fig. 1). We establish that XCI ratios are 
shared for tissues both within and across germ layers demonstrating that XCI is completed 
before any significant lineage decisions are made for embryonic tissues. Additionally, we 
extend population-level modeling of variance in XCI ratios to all well-powered tissues, deriving 
estimates for the number of cells present at the time of XCI and tissue-specific lineage 
commitment. By providing cell counts, temporal ordering of lineage events, and lineage 
relationships across tissues, capturing the statistical commonalities that underlie the inherently 
stochastic nature of XCI is a powerful approach for resolving questions of early developmental 




The folded-normal model accurately estimates XCI ratios from unphased data 
 
A practical consequence of bulk RNA-sequencing is that the XCI ratio of a tissue can be 
estimated from the direction and magnitude of X-linked allele-specific expression. For a tissue 
with 75% of cells carrying an active maternal X-allele, approximately 75% of RNA-sequencing 
reads for heterozygous loci are expected to align to the maternal X-allele (Fig. 2a). However, 
allelic expression for any given gene is affected by a variety of factors both biological (e.g., 
eQTLs) and technical (e.g., read sampling). To derive robust estimates, we aggregate allelic 
expression ratios across well-powered intra-genic heterozygous SNPs for a given tissue, 
providing a chromosome wide-estimate of the tissue XCI ratio (Fig, 2a).  
 
When aligned to a reference genome, reference alleles will be composed of both 
maternal and paternal alleles for a given sample. It follows that reference allelic expression 
ratios represent the expected expression ratios from both the maternal and paternal alleles 
given the XCI ratio of the tissue (Fig. 2a). To account for this, folding the reference allelic 
expression ratios about 0.5 aggregates the imbalanced allelic expression within the tissue 
across the two alleles, enabling the magnitude of the XCI ratio to be estimated from unphased 
expression data by fitting a folded distribution21,22 (see methods, Fig. 2a, b).  
 
 To assess the accuracy of the folded-normal model in estimating XCI ratios, we test our 
approach with phased bulk RNA-sequencing data from the EN-TEx23,24 consortium, a total of 
49 tissue samples from 2 female donors spanning 26 different tissues. Comparing the 
unphased estimates derived with the folded normal model to the phased median allelic 
expression per sample, we find nearly perfect XCI ratio estimate correspondence for ratios 
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greater than 0.6 (Fig. 2c). For samples skewed closer to the folding point of 0.5, model 
misspecification of the underlying distribution makes the estimate overconservative.  
 
Our approach for estimating XCI ratios exploits the fact that aggregating allelic 
expression across numerous heterozygous loci averages mechanisms outside of XCI that may 
impact the allelic expression of X-linked genes. An intriguing and well-documented example of 
such a mechanism is escape from inactivation where a gene is biallelically expressed from 
both the active and inactive X-alleles within a cell25. Escape from inactivation is relatively 
common with between 15-30% of genes on the X-chromosome exhibiting evidence for 
escape25,26. While we exclude known escape genes25 from our folded-normal XCI ratio 
estimates, it is very likely unannotated escape genes are present within the data and may 
impact our XCI ratio estimates. To identify the impact of escape on our XCI ratio estimates, we 
derive folded-normal XCI ratio estimates while either excluding or including known escape 
genes and then compare these to the phased XCI ratio of tissues excluding the known escape 
genes (Fig. 2d). Including known escape genes results in an increased bias for underestimated 
XCI ratios with the folded-normal model (Fig. 2d). By comparing allelic ratios of known escape 
genes to all other genes in EN-TEx tissues with XCI ratios >= 0.7, we clearly see escape 
genes have balanced biallelic expression contributing to the potential for underestimating XCI 
ratios when including escape genes (Fig. 2e).  
 
To assess XCI and escape more broadly, we capitalize on the tissue sampling structure 
of the Genotype-Tissue Expression (GTEx v8) dataset (Supp. Fig. 1). From an average of 56 
+- 23.5 (SD) well-powered heterozygous SNPs per sample (Supp. Fig. 2), we derive robust 
XCI ratio estimates for 4658 GTEx tissue samples spanning 49 different tissues (Supp. Fig. 3). 
Plotting the aggregated gene-level allelic expression ratios for all GTEx samples binned by 
tissue-level XCI ratio estimates reveals a heavy tail towards balanced allelic expression within 
more skewed tissues, indicative of novel escape genes (Fig. 2f).  
 
Escape genes exhibit consistent cross-tissue biallelic expression 
 
Our method to quantitatively determine the tissue XCI ratio via aggregating signal 
across genes is especially well-suited to explore escape from XCI within the GTEx dataset 
(Fig. 2e). Our basic strategy for detecting escape genes is to calculate each gene’s 
consistency with the aggregate chromosomal XI ratio. Assessing all X-linked genes utilized in 
our GTEx XCI ratio estimates (Fig. 3a) and previously annotated constitutively escape genes25 
results in a wide range of correlations between gene and tissue XCI ratios, exemplified by the 
genes SHROOM4 and TCEAL3 (Fig. 3b). As expected, the transcripts associated with XCI, 
namely, XIST and TSIX, show some of the highest correlations to the tissue XCI ratio (i.e., top 
8.7%, Fig. 3b). Similarly, known escape genes exhibit some of the smallest correlations (Fig. 
3b). Interestingly, several genes previously annotated as escape do exhibit rather strong 
correlations to the XCI ratio of tissues. We find that increased gene expression is linked to 
increased correlation to the tissue XCI ratio (Fig. 3c) suggesting that some gene variation with 
respect to the tissue XCI ratio is technical, reflecting read sampling at low expression. At 
matched expression levels, previously annotated escape genes have smaller tissue-gene XCI 
ratio correlations compared to all other genes (Fig. 3c), demonstrating that escape genes are 
less correlated to the tissue XCI ratio as expected by expression levels alone.  
 
From our analysis in the EN-TEx dataset, we find escape from inactivation results in a 
bias for, rather than complete, balanced allelic expression (Fig. 2e), explaining how some 
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escape genes retain significant correlations to tissue XCI ratios in the GTEx dataset. To 
comprehensively test the degree to which escape produces balanced allelic expression, we 
construct a one-sided test to detect whether a gene consistently trends towards balanced 
biallelic expression regardless of the XCI ratio of the tissue (see methods, Supp. Fig. 4). We 
restrict the tissue samples to have an estimated folded XCI ratio >= 0.7 to increase the power 
to detect balanced biallelic expression in opposition to the XCI ratio. Using this approach for 
the known escape genes results in the expected enrichment of significant p-values (Fig. 3d-e, 
Supp. Fig. 4). We apply stringent filters for calling escape status and select for genes that 
exhibit strong escape signal (Fig. 3 d). Some previously annotated escape genes that exhibit 
slight escape signal fail to pass our filters (PLXN3B, Fig. 3 d). This may reflect variation in 
escape across tissues.  
 
Focusing on escape that generalizes across tissues, the genes previously unannotated 
for constitutive escape that display evidence for escape are ARHGAP4, ATRX, BTK, CASK, 
CLIC2, COX7B, CTPS2, CXorf36, EMD, F8, MECP2, MPP1, NLGN4X, PDZD4, PGK1, PLP1, 
RPL36A, SASH3, SEPT6, STARD8, VSIG4 (Fig. 3d-e, Supp. Fig. 4). Revisiting these genes 
within the literature, several have prior evidence for escape typically limited to a specific tissue: 
ATRX (cell lines27), BTK (PBMCs28), CLIC2 (escapes in skin25), COX7B (mouse embryonic 
stem cells29), CTPS2 (previous escape30), CXorf36 (escape in tumors31), NLGN4X (variable 
escape25), SEPT6 (B-cells32), VSIG4 (escape in mouse spleen33). Our results suggest these 
genes escape inactivation more broadly than previously reported. In addition, our analysis 
provides supporting evidence of escape for 32 previously annotated escape genes and 
supporting evidence of inactivation for 133 genes (Supp. Table 1).  
 
XCI is completed prior to germ layer specification 
 
Having developed an approach to measure XCI ratios from unphased data, we turn to 
assessing the degree to which XCI ratios are shared across tissues within individuals. As an 
initial visualization of XCI ratios across tissues, we order all female GTEx donors by their 
average XCI ratio and plot the ratio for all tissues grouped by germ layer (Fig. 4a, Supp. Fig. 
5). XCI ratios qualitatively appear consistent across all tissues and the three germ layers (Fig. 
4a, Supp. Fig. 5). To test the degree of shared XCI ratios, we ask how well individual tissues 
predict highly skewed donor’s average XCI ratio across the remaining tissues (Supp. Fig. 6). If 
the XCI ratio is consistent across all tissues then every tissue is expected to perform well when 
predicting skewed donors. Across various thresholds for defining skewed donors, we see that 
performance is high and consistent across all tissues, suggesting XCI ratios are generally 
shared across all tissues for an individual (Supp. Fig. 6).  
 
Since folded ratios capture only the magnitude of the tissue XCI ratio, two tissues with 
XCI ratios in opposite parental directions might appear similar. To investigate whether the 
parental direction of XCI differs for the same individual between two tissues, we turn to shared 
SNP-level allelic ratios across tissues for individual donors. If an expressed heterozygous SNP 
is captured for two different tissues of an individual, the reference allele is on the same 
haplotype and maintains directional allelic information. Thus, calculating the correlation of 
reference SNP allelic ratios for shared SNPs between two tissues can reveal whether those 
tissues share the same XCI direction (Supp. Fig.7). For donors with at least 10 tissues, the 
average percent of tissues exhibiting switched XCI is 8.3%, suggesting switched XCI occurs 
infrequently. Interestingly, XCI switching is concentrated in a few tissues with 12 out of 49 
being significantly enriched for instances of switched XCI (Supp. Fig. 7). This holds true for the 
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phased EN-TEx data as well, where only the liver, ovary, and omental fat pad change parental 
XCI ratio directions (Supp. Fig. 7). One plausible explanation for this effect is that the XCI ratio 
for some tissues is subject to additional sources of variability compared to other tissues, such 
as lineage specific sampling (See section ‘Cell population estimates at the time of tissue-
specific lineage commitment’). 
 
The broad sampling of different tissues present within the GTEx dataset enables a well-
powered investigation of shared XCI ratios across tissues. Importantly, stratifying these tissue 
comparisons by germ layer lineage relationships should resolve the temporal ordering of XCI 
and germ layer specification within the human embryo. If XCI occurs before germ layer 
specification, tissue XCI ratios are expected to positively covary across tissues from different 
germ layer lineages (Fig.1a). In contrast, if XCI occurs after germ layer specification, the XCI 
ratio of each germ layer is set independently and there is little expected covariance in XCI 
ratios for tissues from different germ layers (Fig.1b). We compute correlations of the XCI ratio 
for combinations of tissues derived from either the same or different germ layers, exemplified 
in Figure 4 panel b. Tissues sharing the same germ layer lineage produce strictly positive 
significant correlation values ranging from 0.25 to 0.90 (Fig. 4c1), demonstrating XCI ratios are 
shared within individual germ layer lineages. Strikingly, significant positive ratio correlations for 
tissues derived from different germ layers are on the same order as the within germ layer 
comparisons, ranging from 0.24 to 0.87 (Fig. 4c2, Supp. Fig. 6). The fact tissues derived from 
different germ layers covary for their XCI ratio strongly suggests XCI is completed prior to 
germ layer specification and the initial embryonic XCI ratio is propagated through all germ 
layer lineages.  
 
Cell population estimate at the time of XCI 
 
 The fact XCI ratios are shared across tissues suggests the initial embryonic XCI ratio 
determined at the time of inactivation is propagated through development. Population level 
variance in adult XCI ratios thus reflects the sample distribution during XCI, which depends on 
the number of cells present during inactivation. We derive estimates for the number of cells 
present at the time of inactivation by modeling XCI ratio variance from tissue-specific ratio 
distributions across donors (Fig. 5a, Supp. Fig. 8). Using a maximum likelihood approach, we 
fit estimated models to the tails of the empirical XCI ratio distributions to account for the 
uncertain unfolded XCI ratio estimates between 0.4 and 0.6 (Fig. 5a, see methods). The cell 
number estimates derived from all well-powered tissues range from 6 to 16 cells (Fig. 5b), i.e., 
approximately within a single cell division, demonstrating a striking degree of similarity in 
population level XCI ratio variance across the assessed tissues. By our estimates, human XCI 
is completed at a time in the embryo when between 6 and 16 cells are fated to become all 
embryonic tissues.  
 
Cell population estimates at the time of tissue-specific lineage commitment 
 
Tissue-specific lineage commitment can be modeled as a random sampling event from 
a pool of unspecified progenitor cells. In the context of XCI, the XCI ratio of the newly specified 
tissue is dependent on the prior XCI ratio of the progenitor pool and the number of cells fated 
for that tissue and can be modeled as a binomial sampling event (Fig. 5c). As such, the GTEx 
dataset offers a unique opportunity to capture this tissue-specific XCI variance and model the 
number of cells present at the time of tissue-specific lineage commitment across a broad range 
of human tissues. 
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To capture the tissue-specific variance in XCI as it relates to the prior embryonic XCI 
ratio, we model the deviation of tissue-specific XCI ratios from the average donor XCI ratios for 
all donors of a given tissue (see Methods, Fig. 5d, 46 well-powered tissues). Our model follows 
the logic that tissues with large variation in their deviation from average donor XCI ratios are 
derived from a smaller pool of cells, a consequence of increased variability due to small 
sample size effects. Intriguingly, we find a strong negative relationship between our estimated 
cell numbers at the time of tissue-specific lineage commitment and the probability of a tissue 
switching the direction of XCI in comparison to other tissues of an individual (Supp. Fig. 7). 
This is in line with the model that tissues derived from smaller stem cell pools are subject to 
increased XCI ratio variability and thus more likely to produce a sample of cells with their XCI 




In this work, we exploited the random, permanent, and developmentally early nature of 
XCI to investigate characteristics of early lineage specification events during human 
development. By analyzing variance in XCI ratios across tissues and individuals, we showed 
human XCI is completed before tissue specification and the stochastically determined XCI ratio 
set during embryogenesis is a shared feature across all tissue lineages. We estimate between 
6-16 cells are fated for all embryonic tissues at the time of XCI completion. Additionally, we 
provide estimates of the number of cells present during tissue-specific lineage specification for 
46 different tissues. To conduct this analysis, we developed a method to estimate the ratio of 
XCI using unphased allele-specific expression, a highly scalable approach applicable to any 
bulk RNA-sequencing sample. 
 
As our approach to estimate XCI ratios is independent of the underlying genes used to 
assess allele-specific expression, it can be applied across systems with variable expression 
profiles, such as tissues, for comparative XCI analysis. As such, our method is well-suited for 
taking advantage of the extensive cross-tissue data of the GTEx dataset and for extracting the 
whole-body lineage relationships present therein. We show that XCI ratios are shared across 
all tissues for an individual, providing insight into the observed variance of XCI ratios in normal 
female populations, an area of ongoing debate10,34,35,36. Our results indicate that the initial 
embryonic XCI ratio is propagated through development and is a shared feature across all 
tissue lineages. This demonstrates that the stochasticity of the initial choice for inactivation 
within the embryo has a measurable impact on XCI ratios in adult females. Additionally, our 
results determining the number of cells fated for tissue-specific lineage commitment revealed a 
broad range of cell numbers, identifying an additional layer of variation where developmental 
stochasticity can have a phenotypic impact. Tissues derived from smaller stem cell pools may 
be more susceptible to stochastic developmental events, such as deleterious de novo 
mutations, a possibility strongly suggested by our finding that tissues with small estimated 
stem cell pools are more likely to switch the direction of XCI within an individual.   
 
Our work is part of a broader history of using X-linked mosaicism as a tool for studying 
lineage relationships, with studies ranging from investigations of early lineage events in mice6 
to ascertaining tumor clonality37. Typically, these approaches will capitalize on a single locus of 
the X-chromosome to determine XCI status38. When using allele-specific expression, the use 
of a fully phased genome would similarly allow any single heterozygous X-linked loci to mark 
the expressed X, though generating a phased genome is generally cost prohibitive. 
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Importantly, the variability in expression across systems and the fidelity of inactivation for 
individual genes (escape from XCI) means that robust cross-tissue evaluation of XCI using 
single X-linked loci has been challenging to conduct. One of our methodological contributions 
is to demonstrate the allelic expression imbalance generated via XCI can be aggregated to 
provide near-perfect estimates of XCI ratios, even in the absence of phased information. 
Indeed, while none of our estimated XCI ratios are phased at the SNP-level, the observed 
error in our estimates by aggregating allelic expression correctly across SNPs is lower than 
any single locus can provide.     
 
While GTEx represents the premier dataset for human cross-tissue functional 
genomics, more data is always helpful. As our approach for estimating XCI ratios is applicable 
to any bulk RNA-sequencing data, we envision this work providing an informative control for 




GTEx and EN-TEx data 
 
Fastq files for all female donors from the GTEx project v7 release20 were obtained from 
dbGaP accession number phs000424.vN.pN. BAM files for additional female samples from the 
v8 release were obtained from the associated AnVIL repository 
(gtexportal.org/home/protectedDataAcccess). Phased expression data from the EN-TEx 
project23,24 were obtained in collaboration with the ENCODE consortium. EN-TEx data is 
available on the online portal23.  
 
RNA-seq alignment and SNP identification 
 
For aligning RNA-sequencing data, the GRCh38.p7 human reference genome using 
GENCODE v.25 annotations was generated with STAR v2.4.2a39 and data was aligned with 
STAR v2.4.2a or STAR v2.5.2b. STAR was run using default parameters with per sample 2-
pass mapping. BAM files for the additional GTEx v8 samples (originally aligned to 
GRCh38.p10 with GENCODE v.26 annotations) were sorted using samtools v1.940 and 
converted to fastq files using bedtools v.2.26.041. For each sample, alignment to the X-
chromosome was extracted using samtools and passed to GATK42,43 for SNP identification. 
Using GATK v.4.1.3.0 and following the best practices workflow for RNAseq short variant 
discovery (GATK best practices), we used the following pipeline of GATK tools using default 
parameters unless otherwise stated: AddorReplaceReadGroups -> MarkDuplicates -> 
SplitNCigarReads -> HaplotypeCaller (-stand-call-conf 0.0) -> SelectVariants (-select-type 
SNP) -> VariantFiltration. The following filters were used in VariantFiltration to set flags for 
downstream filtering: QD < 2.0, QUAL < 30.0, SOR > 3.0, FS > 60.0, MQ < 40.0, MQRankSum 
< -12.5, and ReadPosRankSum < -8.0. These filters were determined from GATK 
recommendations and empirical evaluation of the identified SNPs’ metrics.  
 
SNP quality control 
 
SNPs identified through GATK were further filtered by various metrics to increase 
confidence in SNPs identified from RNA-sequencing data and ensure well-powered SNPs for 
allele-specific expression analysis. The resulting .vcf files from GATK were filtered to only 
contain SNPs present within dbSNP44. The remaining SNPs were filtered to be heterozygous 
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with 2 identified alleles and at least 10 reads mapped to each allele for a minimum threshold of 
20 reads per SNP. Additionally, SNPs were required to pass the SOR, FS, and 
ReadPosRankSum filters set in the GATK pipeline. Only SNPs located within annotated genes 
(excluding the PAR regions of the X-chromosome) were considered and in the case of multiple 
identified SNPs in the same gene for a sample, the SNP with the highest total read count was 
taken as the max-powered representative for that gene. SNPs with a total read count above 
3000 were excluded as they demonstrated a uniform distribution of allelic expression (Supp. 
Fig. 2).   
  
Gene filtering (reference bias and XCI escape) 
 
From the observation of a heavy tail towards allelic expression in the reference direction 
across all called SNPs in the GTEx dataset (Supp. Fig. 2), we compiled gene specific 
distributions of allelic expression to determine if a select few genes/SNPs were at fault. The 
majority of genes demonstrated distributions of relative allelic expression centered around 0.5 
with several considerable exceptions, some genes exhibited bimodal or extremely biased 
distributions (Supp. Fig. 2). We excluded genes that failed the dip test for bimodality as well as 
the top and bottom 5% of genes ranked by the deviation of their mean reference expression 
ratio from 0.5 (Supp. Fig. 2). Additionally, we excluded genes previously annotated to 
constitutively escape XCI25. In total, we end up with well-powered SNPs from 542 genes along 
the X-chromosome for modeling XCI ratios.  
 
Folded normal model for estimating XCI ratios 
 
We aggregate the allelic expression imbalance of the X-chromosome over both alleles 
by folding the reference allelic expression ratios about 0.5 (Fig 2a-b). To obtain our XCI ratio 
estimates we fit a folded normal distribution to the folded reference allelic expression ratios of 
each sample, using the maximum log likelihood estimate as the estimated XCI ratio. 
Theoretically, the captured bulk allelic expression for a heterozygous X-linked SNP follows a 
binomial distribution characterized by the read depth of the SNP and the XCI ratio of the 
sample. Without phasing information, the allelic expression of heterozygous X-linked SNPs 
can be characterized by the folded-binomial model21,22. Since SNPs vary in read depth and 
various biological factors (e.g. eQTLs) are not accounted for in the binomial model, we take the 
folded normal model as a continuous approximation. We require samples to have XCI ratio 
estimates derived from at least 10 filtered SNPs for downstream analysis, resulting in 4659 
samples with a mean of 56 well-powered SNPs per sample (Supp. Fig. 3). Additionally, we 
calculate 95% confidence intervals (CI) for each XCI ratio estimate via a nonparametric 
bootstrap percentile approach (n = 200), excluding XCI ratio estimates with a CI width >= .15 
from downstream analysis. For donors with multiple samples for the same tissue, we average 
the XCI ratio estimates together, duplicated tissue samples have minor differences in 
estimated XCI ratios (mean difference in XCI ratios for duplicate tissue samples: 0.018 +- 
0.023 SD).    
 
Gene-tissue XCI ratio correlations 
 
To test an individual gene’s propensity to follow the aggregate chromosomal XCI ratio, 
we calculate Pearson correlations between a gene’s reference allelic expression ratio and the 
estimated XCI ratio (leaving out that gene for all samples in which the gene is detected). We 
calculate these correlations for each of the 542 filtered genes described above and for 45 
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previously annotated constitutively escape genes detected in our dataset. We only consider 
genes detected in at least 30 samples and with an FDR corrected (Benjamini-Hochberg) 
correlation p-value <= .05 determined by a permutation test (n = 10000) for further 
investigation of escape status, resulting in 380 putative inactive genes and the 45 previously 
annotated escape genes.  
 
Testing for escape from XCI 
 
To detect escape genes, it is necessary to compare against genes that undergo 
complete inactivation and do not escape. After they are stratified by mean expression, we 
reason the genes most likely to undergo complete inactivation are genes with high gene-tissue 
XCI ratio correlations within each expression bin (Fig. 3c). Accordingly, we take the top 50% of 
putative inactive genes within each bin to define the null distribution of allelic expression under 
the hypothesis of complete inactivation (191 genes). The remaining 189 putative inactive 
genes and the 45 known escape genes composes our test set. We reason a gene that 
escapes XCI will be biased for balanced biallelic expression regardless of the XCI ratio of the 
tissue. Using only tissues with an estimated XCI ratio >= 0.70, we compute the deviation from 
0.5 (balanced allelic expression) for all genes and calculate the empirical p-value as follows: 
sum( deviation( null inactive genes)  <= deviation( test gene)) / number of genes (Supp. Fig. 
4). We only consider p-values derived from samples with at least 20 null inactive genes 
detected. 
 
Under the null hypothesis of inactivation, genes with strong deviation from a uniform p-
value distribution are strong candidates for escape from inactivation.  We first fit a slightly 
offset negative exponential function to the uniform deviations of the null inactive genes to 
define a threshold for escape while controlling for sample size (Supp. Fig. 4). Additionally, we 
only consider genes with at least 50 computed p-values. An enrichment of low p-values from 
this test is indicative of balanced biallelic expression regardless of the XCI ratio of the tissue. It 
follows that an enrichment of high p-values from this test is indicative of preferential mono-
allelic expression regardless of the XCI ratio of the tissue.  
 
Tissue XCI ratio predicting donor XCI ratio 
 
For the donors that contribute to a given tissue, we calculate the mean XCI ratio across 
all other tissues for each donor. We define skewed donors as having a mean XCI ratio greater 
than or equal to various thresholds (0.65, 0.7, 0.75, 0.8). We calculate the AUROC of a given 
tissue’s XCI ratio predicting skewed donors via the Mann-Whitney U test statistic.   
 
Cross-tissue XCI ratio correlations 
  
For all pairwise combinations of the 49 tissues present within the GTEx dataset, we take 
the subset of donors that contribute both tissues for a given comparison and calculate the 
Pearson correlation for the folded XCI ratio of the tissues. Figure 4c1-c2 depicts only the 
correlation values derived with a sample size of at least 20 donors and an FDR corrected 
(Benjamini-Hochberg) p-value <= .05 derived from a permutation test (n = 10000). 
Supplemental Figure 6 depicts all computed correlations regardless of sample size or p-value. 
 
Inference on direction of XCI ratios 
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 To infer the direction of XCI ratios from unphased data, we look at allelic expression of 
heterozygous SNPs captured in multiple tissues for an individual donor. The reference allele of 
a heterozygous SNP captured in two different tissues of a single donor represents the same 
parental X-allele in both tissues. If the direction of XCI is the same for both tissues, the 
heterozygous SNP is expected to exhibit the same degree of reference allelic expression 
across the two tissues (positive correlation). If the direction of XCI is different, reference allelic 
expression will be inverted for one of the tissues resulting in a negative correlation. For each 
donor, for all pairwise combinations of their donated tissues with XCI ratios >= 0.6, we 
calculate Pearson correlations for unfolded reference allelic expression ratios using only SNPs 
detected in both tissues (Supp. Fig. 7). We only use SNPs that are within the previously filtered 
542 genes described above and only consider correlations derived from tissue comparisons 
with at least 30 shared SNPs. Using positive or negative correlations as a readout for switched 
XCI direction between tissues, we perform Fisher’s exact test with a Benjamini-Hochberg 
correction to identify any tissue significantly enriched for switching XCI directions.    
 
Evaluating XCI cell number estimates 
 
XCI is a binomial sampling event defined by the number of cells present during 
inactivation and the equal probability of inactivation between the alleles (N = # of cells, p = 
0.5). As such, the variance in XCI ratios within a population is directly linked to the number of 
cells present during XCI. We derive estimates for the number of cells present during XCI by 
fitting a normal model to tissue-specific XCI skew distributions as a smoothened estimate for 
the underlying binomial distribution. We take the theoretical variance from the binomial model 
as the variance for the normal approximation.  
       	
,,       .. , where p,q = probability of allelic inactivation. 
 
For a range of cell numbers (N = 2:50), we select the normal model with minimum error 
between its CDF and the empirical XCI ratio CDF of a given tissue for the tails of the 
distribution (XCI ratio <= 0.4 and XCI ratio >= 0.6, Supp. Fig. 8). This accounts for the 
uncertain folded 0.5 – 0.6 XCI ratios estimates in the unfolded space. We calculate 95% CIs 
for each estimated cell number via a nonparametric bootstrap percentile approach (n = 2000). 
We only consider cell number estimates from tissues with at least 10 donors.   
 
Evaluating tissue-specific lineage cell number estimates 
 
We model tissue-specific lineage specification as a cell sampling event from a large 
pool of cells. As such, the XCI ratio of a tissue will follow a binomial model defined by the 
number of cells fated for that tissue and the XCI ratio of the embryo (Fig. 5c). 
 
	
 ~ , ,     , 	
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For a given tissue, across donors with variable XCI ratios (	
) the variation in the 
tissue XCI ratio is defined by the constant , the number of cells fated for that tissue. To 
estimate this constant, we calculate z-scores for each tissue-donor pair of a given tissue using 
the mean XCI ratio of all other tissues for each donor as an approximation for 	
. 
 
   	
  	




      !  
 
 
As the standard deviation of a distribution of z-scores is 1, we solve for : 
 
                  " 

∑    $  1 , where m = number of donors for a given tissue 
 
    ∑   
 
We calculate 95% CIs for each  via a nonparametric bootstrap percentile 
approach (n = 2000) using the  ! distribution. We require a tissue to have at least 10 
donors in order to calculate . 
 
Data analysis and visualization 
 
All analysis was conducted in R version 4.0.545. Graphs were generated using the ggplot246, 
ComplexHeatmap47, karyoploteR48, and base R packages. 
 
Data and code availability 
 
The code for all analysis is available on Github 
github.com/JonathanMWerner/human_cross_tissue_XCI. Processed data is available on the 
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Timing of XCI determines lineage-specific XCI ratio probability 
 
a, Schematic representing completed XCI before germ layer specification. Each germ layer 
inherits the same randomly determined XCI ratio set prior to germ layer lineage specification. 
The probability distribution of XCI is determined by the number of cells present during 
inactivation. b, Schematic representing completed XCI after germ layer specification. The XCI 
ratio for each germ layer is set independent of one another, together along with variation in cell 
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The folded-normal model accurately estimates XCI ratios from unphased bulk RNA-
sequencing data 
 
a, Schematic demonstrating how allelic expression of heterozygous SNPs reflect the XCI ratio 
of bulk tissue samples. Aligning expression data to a reference genome scrambles the 
parental haplotypes and reference allelic expression ratios will represent both the expected 
maternal and paternal allelic expression ratios given the XCI ratio of the tissue. Folding the 
reference allelic expression ratios captures the magnitude of the tissue XCI ratio. b, 
Distributions of reference allelic expression ratios for identified heterozygous SNPs across 
tissue samples exhibiting a range of bulk XCI ratios. Both the unfolded (top row) and folded 
distributions with the fitted folded normal model (bottom row) are shown. c, For the EN-TEx 
tissue samples, the phased median gene XCI ratio is plotted against the unphased XCI ratio 
estimate from the folded normal model. The folded normal model produces near identical XCI 
ratio estimates for samples with XCI ratios greater than or equal to 0.60. d, Deviation of the 
folded normal model from the phased median gene XCI ratio when excluding or including 
known escape genes. e, Aggregated folded reference allelic expression distributions for known 
escape and inactive genes in EN-TEx tissues with XCI ratios >= 0.70. Balanced allelic 
expression in opposition to the XCI ratio of the tissue most likely explains the increased 
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underestimation of XCI ratios from the folded normal model when including escape genes. f, 
Aggregated gene-level folded reference allelic expression ratio distributions for all GTEx 
samples grouped by their estimated tissue XCI ratios (withholding known escape genes). The 
long tails of the distributions towards balanced biallelic expression are indicative of novel 
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Genes that escape XCI exhibit balanced biallelic expression across XCI skewed tissues  
 
a, The genomic location and number of GTEx samples each gene is detected for the 542 
genes that pass our quality control filters. b, All 542 genes and 45 known escape genes 
ranked by the Pearson correlation coefficient for each gene’s allelic expression and the XCI 
ratio of the tissue for samples that detect that gene. c, Distributions of gene-tissue XCI ratio 
correlations for all 542 genes and 45 escape genes, binned by average expression. The range 
of average expression is binned into 4 equally spaced bins. For each expression bin, we 
labeled the top 50% of genes as inactive genes, genes that confidently follow the tissue XCI 
ratio, and the bottom 50% of genes as putative inactive genes, as they are potentially a mix of 
inactive and unannotated escape genes. d, The deviation from the uniform distribution is 
plotted for each gene’s p-value distribution, calculated from our one-sided test to detect 
balanced biallelic expression in tissues with XCI ratios >= 0.70 (see methods). The deviation of 
inactive genes was used as a threshold to identify robust escape genes and classify the 
putative inactive genes as either confident inactive or novel escape. e, The aggregated p-value 
distributions for inactive, known escape, and the putative inactive genes now classified as 
confident inactive and novel escape are plotted.  
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Figure 4 
 
XCI ratios are shared across germ layer lineages 
 
a, Heatmap of all estimated XCI ratios for the tissues of each donor, with donors ordered by 
their mean XCI ratio across tissues and tissues grouped by germ layer lineage. Black indicates 
no tissue donation for that donor-tissue pair. b, Examples of within and across germ layer 
lineage comparisons of XCI ratios. Each data point represents the estimated XCI ratios of the 
two indicated tissues for a single donor. c, All significant (FDR corrected p-value <= 0.5, 
permutation test n = 10000) Pearson correlation coefficients for within and across germ layer 
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XCI and tissue lineage specification can be timed to a pool of cells by exploiting observed 
variability 
 
a, Example tissue demonstrating the model for estimating cell numbers at the time of XCI 
using the population-level variance in XCI ratios. We fit normal distributions, as a continuous 
approximation of the underlying binomial distribution of XCI ratios, to the tails of tissue-specific 
XCI ratio distributions (shaded in blue), which accounts for the uncertain 0.40-0.60 unfolded 
XCI ratio estimates (shaded in grey). b, The resulting estimated cell numbers present during 
XCI derived from the XCI ratio variance of all tissues with at least 10 donors. Error bars are 
95% confidence intervals and tissues are grouped by germ layer lineage. Cell number 
estimates range from 6-16 cells across all tissues. c, Schematic for our model of tissue lineage 
specification and the implications for tissue-specific XCI ratios. The XCI ratio of a tissue is 
dependent on the prior XCI ratio of the embryo and the number of cells selected for that tissue 
lineage. These two features define the binomial distribution for that tissue’s XCI ratio. d, 
Estimated number of cells selected for individual tissue lineage specification of 46 different 
tissues. Error bars represent 95% confidence intervals. The top bar graph plots the variance in 
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the distribution of tissue XCI ratio deviation from the average XCI ratio of each donor for that 
tissue. Our model follows the logic that lineage specification of a small pool of cells increases 
variation in XCI ratios, resulting in increased likelihood a tissue will deviate from the average 
donor XCI ratio.   
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